Mid – Late 1970’s Emergence of recombinant DNA technology Concerns among both scientific community and general public:  Public health and safety  Environmental.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

1 Health Information Technology (HIT) California Council on Science and Technology February 2009 Alfonso F. Cardenas, UCLA.
THE NIH RECOMBINANT DNA 2002 GUIDELINES East Carolina University September 5, 2007.
Infant & Child Food Safety Handbook for Healthcare facilities Project supported with a grant from International Association of Infant Food Manufacturers.
Identify source area and COCs Determine nature and extent of discharge Evaluate potential risks to public health and the environment Develop Investigation.
Neighborhood Watch: University Compliance Developments related to Research Susan Rafferty, Interim Director Office of Institutional Compliance.
Financial Conflict of Interest and Medical Research
Lasting Ethical Implication in Research: The Tuskegee Experience Sapana Panday Widener University.
The scientist as a responsible member of society, ethical issues in research, and the environmental and societal impacts of scientific research On Being.
Outline Introduction to the National Institutes of Health Office of Biotechnology Activities History and Evolution of IBCs: Asilomar to the Present Overview.
Responsible Conduct of Research & Research Compliance Adam J. Rubenstein, Ph.D. Director of Research Compliance Old Dominion University Office of Research.
Office of the Vice President for Research
1 NIH Clinical Center,CTSAs NIH Molecular Libraries Initiative Disease Target ID Assay Dev. HTS Probe to Lead Pre- Clinical FDA IND Ph. IPh. IIPh. III.
Coming Soon... Mandatory Biosafety Training David W. Emery, Ph.D. Research Associate Professor of Medicine & Chair, Institutional Biosafety Committee On.
What will be studied? What are the risks? September 10, 2007 National Emerging Infectious Diseases Laboratories.
NOAA GRANTS MANAGEMENT DIVISION NESDIS ADMINISTRATORS MEETING OCTOBER 27, 2005.
The National Academies’ Board on Life Sciences Dr. Frances Sharples Director National Research Council National Research Council.
Safety and Loss Control
Research and Biological Safety Office Environmental Health and Safety
Research Bioethics Consultation: More potential than sequencing genomes Benjamin S. Wilfond MD Seattle Children’s Hospital Treuman Katz Center for Pediatric.
Research Protocol Registration at WUStL Institutional Biological and Chemical Safety Committee/ Environmental Health and Safety Joe Kanabrocki Biological.
ACCESS TO UK RESEARCH OUTPUTS The developing RCUK position
Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee.
Newborn Screening Translational Research Network Coordinating Center Duane Alexander, M.D. Director, Eunice Kennedy Shriver National Institute of Child.
INSTITUTIONAL REVIEW OF BIOSAFETY RESEARCH Review of Institutional Biosafety Committee Application Form Robert J. Hashimoto The University of Kentucky.
Dual Use Research of Concern Boston University and Boston Medical Center.
Mark Keim, MD Centers for Disease Control and Prevention.
Objective BT11.02:Analyze transgenic animals.. Early beginnings Biotechnology – collection of scientific techniques that use living cells and molecules.
XXX_DECRIPT_MON00/1 Quality and impact of Social Science and Operations Research by the Special Programme in Human Reproduction Department of Reproductive.
Safety organization and training. The biosafety officer and biosafety committee A safety policy, A safety manual, and Supporting programmes for their.
STRATEGIES FOR SUCCESS 1. Build and Sustain a Vital Research Environment Understand the NIH extramural research program –Know the guidelines, deadlines,
Managing Your Grant Award August 23, 2012 Janet Stoeckert Director, Research Administration Sr. Administrator, Basic Sciences Keck School of Medicine 1.
1 Investigating Fraud & Abuse Violations in Medical Research Janet Rehnquist, Esq. Venable LLP th Street, NW Washington, DC
Overview of the USDA Biotechnology Risk Assessment Grants Program Deb Hamernik, PhD National Program Leader, Animal Physiology US Department of Agriculture.
Animal Research at Princeton Prepared by Stuart Leland Director, Research Integrity and Assurance For use and distribution by the Princeton University.
11/2003 CML Archived File The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may.
Pipelines. Fragile Infrastructure
Meeting of the UNEP Advisory group on Endocrine Disrupting Chemical,Geneva, September 2015 Caroline N. Wamai Senior Principal Chemist Ministry of.
1 Judy Hewitt, PhD On Detail to Office of Extramural Research National Institutes of Health May 18, 2015 Center for Scientific Review Advisory Council.
1 Institutional Responsibilities in Research Management Ann Pollack Assistant Vice Chancellor - Research September 29, 2009.
Public Health Assessment Process Jack Hanley, M.P.H. Environmental Health Scientist Agency for Toxic Substances and Disease Registry.
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
1 Vaccines and Related Biological Products Advisory Committee (VRBPAC) Meeting Detection of Porcine circovirus (PCV) and PCV DNA Sequences in U.S. Licensed.
National Institutes of Health U.S. Department of Health and Human Services Superfund Research Program (R13) Alicia V. Lawson, MPH Health Specialist NIEHS.
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS.
1 Nanoscale Materials Stewardship Program Environmental Summit May 20, 2008 Jim Alwood Chemical Control Division Office of Pollution Prevention and Toxics.
How is a grant reviewed? Prepared by Professor Bob Bortolussi, Dalhousie University
 Welcome ◦ Amanda Athey, Director, Graduate School  Student Experience  Funding Opportunities ◦ Rebecca Drake, Research Administrator, Office of Research.
Business Services Safety Office N EW E MPLOYEE O RIENTATION.
Ethics & Engineering Design January 26, 2005 Dr. Nathan Ensmenger University of Pennsylvania
Emergency Medical Workgroup Charge: –Identify the communications needs and requirements of emergency medical users; –Review proposals by other work groups.
ESSB 6656 Overview and Scope of the Select Committee on Quality Improvement in State Hospitals April 29, 2016 Kevin Black, Senate Committee Services Andy.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
The IBC is: The Institutional Biosafety Committee (aka Biohazards Committee)
Institutional Development Award (IDeA) Program – Infrastructure for Clinical and Translational Research (IDeA-CTR) J. Rafael Gorospe M.D. Ph.D. Medical.
Richmond Kids First: Building Power thru a Ballot Effort.
Laboratory Safety 1 Navigating the University: Laboratory Safety James Gibson, PhD, MPH Executive Director, Office of Environmental Health & Safety Descanso.
Overview of the NIH Guidelines for Research Involving Recombinant DNA Molecules This is an edited combination of Haverford College’s IBC training materials.
Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.
ROLE OF THE INSTITUTIONAL BIOSAFETY COMMITTEE
NAS Committee on Gene Editing
On Human Gene Editing: International Summit Statement
Grant Writing Information Session
دانشگاه علوم پزشکی بوشهر دانشکده بهداشت
دانشگاه علوم پزشکی بوشهر دانشکده بهداشت
CORPORATE & ACADEMIC GOVERNANCE STRUCTURE
Human Gene Therapy Institutional Review Procedures
CHALLENGES TO BIOMEDICAL RESEARCH
Institutional Biosafety Committee (IBC) OVERVIEW
Presentation transcript:

Mid – Late 1970’s Emergence of recombinant DNA technology Concerns among both scientific community and general public:  Public health and safety  Environmental impact  Potential ethical and social implications

Asilomar Scientific Summit (1975) Premise: – Scientists taking responsibility for the risks of their research Outcomes: -- Reaffirmation of the need for guidelines -- Establishment of a new federal oversight committee

Oversight System NIH Recombinant DNA Molecule Program Advisory Committee – Launched process of developing NIH guidelines for recombinant DNA oversight – Made recommendations about local oversight Award NIH Grants for recombinant DNA research only after review of risks by an institutional “biohazards” review committee – Review of physical containment and facilities – Consideration of local circumstances

First NIH Guidelines Published in July 1976 Established responsibilities of investigators and institutions